Both in Biotechnology
ADMA Biologics vs Hemab Therapeutics Holdings
Over the past year ADMA returned +20.4% and COAG returned +9.4%; their daily moves had a correlation of 0.14.
ADMA +20.4% COAG +9.4%Growth of $1, one year, split-adjusted
| Metric | ADMA | COAG |
|---|---|---|
| Price | $11.11 | $43.10 |
| Market cap | $2.49B | $2.01B |
| Today | +0.45% | +4.66% |
| 1 month | +9.9% | +40.9% |
| 6 months | +8.4% | — |
| Year to date | −39.1% | — |
| 1 year | −28.2% | — |
| Revenue growth (YoY) | +2.0% | — |
| Gross margin | 69.4% | — |
| Net margin | 30.4% | — |
| P/E (TTM) | 14.7× | — |
| Price / sales | 4.9× | — |
| Net cash | -$60.6M | $457.5M |
| Dividend yield | — | — |
| Volatility (60d) | 38.5% | — |
| Short % of float | 9.1% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).